2-(6-fluoro-2-methylcyclohexa-1,3-dien-1-yl)-4-N-piperidin-4-yl-4a,8a-dihydro-1,7-naphthyridine-4,6-diamine
C20H26FN5 — CID 163826234
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(6-fluoro-2-methylcyclohexa-1,3-dien-1-yl)-4-N-piperidin-4-yl-4a,8a-dihydro-1,7-naphthyridine-4,6-diamine
2-(6-fluoro-2-methylcyclohexa-1,3-dien-1-yl)-4-N-piperidin-4-yl-4a,8a-dihydro-1,7-naphthyridine-4,6-diamine (PubChem CID 163826234) has the molecular formula C20H26FN5 and a molecular weight of 355.46 g/mol. Its IUPAC name is 2-(6-fluoro-2-methylcyclohexa-1,3-dien-1-yl)-4-N-piperidin-4-yl-4a,8a-dihydro-1,7-naphthyridine-4,6-diamine.
Molecular Properties
| Compound Name | 2-(6-fluoro-2-methylcyclohexa-1,3-dien-1-yl)-4-N-piperidin-4-yl-4a,8a-dihydro-1,7-naphthyridine-4,6-diamine |
|---|---|
| PubChem CID | 163826234 |
| Molecular Formula | C20H26FN5 |
| Molecular Weight | 355.46 g/mol |
| Exact Mass | 355.22 |
| IUPAC Name | 2-(6-fluoro-2-methylcyclohexa-1,3-dien-1-yl)-4-N-piperidin-4-yl-4a,8a-dihydro-1,7-naphthyridine-4,6-diamine |
| SMILES | CC1=C(C2=NC3C=NC(N)=CC3C(NC3CCNCC3)=C2)C(F)CC=C1 |
| InChI | InChI=1S/C20H26FN5/c1-12-3-2-4-15(21)20(12)17-10-16(25-13-5-7-23-8-6-13)14-9-19(22)24-11-18(14)26-17/h2-3,9-11,13-15,18,23,25H,4-8,22H2,1H3 |
| InChIKey | NZSTWEPORYFFQZ-UHFFFAOYSA-N |
| XLogP | 2.15 |
| TPSA | 74.80 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 355.46 |
| LogP ≤ 5 | 2.15 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163826234 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.